COMMUNIQUÉS West-GlobeNewswire

-
Amarin Reports Record Fourth Quarter and Full Year 2018 Financial Results and Provides Update on Operations
27/02/2019 -
Nexstim Plc Postpones its 2018 Full Year Results Release to Monday 4 March 2019
27/02/2019 -
111, Inc. Announces the Appointment of a New Chief Financial Officer
27/02/2019 -
Esperite N.V. (ESP) with The Cell Factory has confirmed a long-term effect of extracellular vesicle drug candidate CF-MEV-132 for the treatment of Bronchopulmonary Dysplasia.
27/02/2019 -
Annual Report 2018: GN delivers on guidance with 13% organic growth and EBITA margin increase – 18% organic growth in Q4 2018
27/02/2019 -
ObsEva SA to Hold Fourth Quarter and Full Year 2018 Financial Results and Business Update Call on March 5, 2019
27/02/2019 -
Acacia Pharma Group plc Results For The Year Ended 31 December 2018
27/02/2019 -
The rolling submission to FDA for darolutamide in the U.S. completed
27/02/2019 -
111 to Announce Fourth Quarter and Fiscal Year 2018 Unaudited Financial Results on March 7, 2019
27/02/2019 -
Wildflower Debuts to Celebrities at the Oscars
27/02/2019 -
Ultragenyx Announces Pricing of Public Offering of Common Stock
27/02/2019 -
Adamis Provides Regulatory Update on Sublingual Tadalafil
27/02/2019 -
ASLAN Pharmaceuticals to Partner With BioGenetics on Commercialisation of Varlitinib in South Korea
26/02/2019 -
Precision Therapeutics Inc. Announces Proposed Public Offering of Securities
26/02/2019 -
Apellis Pharmaceuticals Reports Fourth Quarter and Full Year 2018 Financial Results
26/02/2019 -
Supernus Announces Record Full Year 2018 Financial Results
26/02/2019 -
Veloxis to Host Conference Call Following Release of 2018 Annual Report
26/02/2019 -
Flexion Therapeutics to Present at the 40th Annual Raymond James Institutional Investors Conference
26/02/2019 -
Harvard Bioscience Subsidiary Data Sciences International to Participate at SOT 2019 With Presentation and Exhibit
26/02/2019
Pages